Lessons from cholera & Vibrio cholerae

Indian Journal of Medical Research

Volumn 133, Issue 2, 2011, Pages 164-170

  Ghose, Asoke C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Cholera; Cholera toxin; ORS; Vaccine; VBNC; Vibrio cholerae

Indexed keywords

CHOLERA TOXIN; CHOLERA VACCINE; ORAL REHYDRATION SOLUTION;

BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM IDENTIFICATION; CHOLERA; CLIMATE CHANGE; EL NINO; EPIDEMIC; GENE EXPRESSION; HISTORY OF MEDICINE; HUMAN; INCIDENCE; MEDICAL RESEARCH; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENICITY ISLAND; REGULON; REVIEW; VIBRIO CHOLERAE; DIARRHEA; EPIDEMIOLOGY; FLUID THERAPY; HISTORY; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PATHOPHYSIOLOGY;

CHOLERA; CHOLERA VACCINES; CLIMATE CHANGE; DIARRHEA; EPIDEMICS; EPIDEMIOLOGY; FLUID THERAPY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; VIBRIO CHOLERAE;

EID: 79952928216     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Marquez GG. Love in the time of cholera. London: Penguin Books; 1989.
2. Maugham. WS. The painted veil. London: Heinemann; 1925.
3. Chattopadhyay SC. Pundit Mashai. Calcutta: MCSBS Publishers; 1914.
4. Koch R. An address on cholera and its bacillus. Br Med J 1884; 2: 403-407, 453-459.
5. Carter KC. Koch's postulates in relation to the work of Jacob Henle and Edwin Klebs. Med Hist 1985; 29: 353-374.
6. Snow J. On the mode of communication of cholera. London: John Churchill; 1855.
7. Mahalanabis D, Molla AM, Sack DA. Clinical management of cholera. In: Barua D, Greenhough WB. III, editors. Cholera. New York: Plenum; 1992. p. 253-83.
8. [No authors listed]. Water with sugar and salt. Lancet 1978; 2: 300-301.
9. De SN. Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature 1959; 183: 1533-1534.
10. Dutta NK, Panse MW, Kulkarni DR. Role of cholera a toxin in experimental cholera. J Bacteriol 1959; 78: 594-595.
11. Finkelstein RA. Cholera enterotoxin (choleragen): a historical perspective. In: Barua D, Greenough WB. III, editors. Cholera. New York: Plenum; 1992. p. 155-187.
12. Xu HS, Roberts N, Singleton FL, Attwell RW, Grimes DJ, Colwell RR. Survival and viability of nonculturable Escherichia coli and Vibrio cholerae in the estuarine and marine environment. Microb Ecol 1982; 8: 313-323.
13. Colwell RR. Viable but nonculturable bacteria: a survival strategy. J Infect Chemother 2000; 6: 121-125.
14. Alam M, Sultana M, Nair GB, Siddique AK, Hasan NA, Sack RB, et al. Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci USA 2007; 104: 17801-17806.
15. Trucksis M, Michalski J, Deng YK, Kaper JB. The Vibrio cholerae genome contains two unique circular chromosomes. Proc Natl Acad Sci USA 1998; 95: 14464-14469.
16. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, et al. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 2000; 406: 477-483.
17. Rasmussen T, Jensen RB, Skovgaard O. The two choromosomes of Vibrio cholerae are initiated at different time points in the cell cycle. EMBO J 2007; 26: 3124-3131.
18. DiRita VJ. Co-ordinate expression of virulence genes by ToxR in Vibrio choleare. Mol Microbiol 1992; 6: 451-458.
19. Bina J, Zhu J, Dziejman M, Faruque S, Calderwood S, Mekalanos J. ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients. Proc Natl Acad Sci USA 2003; 100: 2801-2806.
20. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993; 341: 703-704.
21. Bik EM, Bunschoten AE, Gouw RD, Mooi FR. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J 1995; 14: 209-216.
22. Faruque SM, Mekalanos JJ. Pathogenicity islands and phages in Vibrio cholerae evolution. Trends Microbiol 2003; 11: 505-510.
23. Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996; 272: 1910-1914.
24. Karaolis DK, Somara S, Maneval DR Jr, Johnson JA, Kaper JB. A bacteriophage encoding a pathogenicity island, a type- IV pilus and a pahage receptor in cholera bacteria. Nature 1999; 399: 375-379.
25. Pascual M, Rodo X, Ellner SP, Colwell R, Bouma MJ. Cholera dynamics and El-Nino southern oscillation. Science 2000; 289: 1766-9.
26. Kovats RS, Bouma MJ, Hajat S, Worrall E, Haines A. El-Nino and health. Lancet 2003; 362: 1481-1489.
27. Lipp EK, Huq A, Colwell RR. Effects of global climate on infectious disease: the cholera model. Clin Microbiol Rev 2002; 15: 757-70.
28. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995; 8: 48-86.
29. Cryz SJ Jr, Kaper J, Tacket C, Nataro J, Levine MM. Vibrio cholerae CVD 103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non- target effects. Dev Biol Stand 1995; 84: 237-244.
30. Richie EE, Punjabi NH, Sidharta YY, Peetosutan KK, Sukandar MM, Wasserman SS, et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103- HgR in North Jakarta, Indonesia, a cholera endemic area. Vaccine 2000; 18: 2399-2410.
31. Holmgren J, Svennerholm AM, Jertborn M, Clemens J, Sack DA, Salenstedt R, et al. An oral B subunit: whole cell vaccine against cholera. Vaccine 1992; 10: 912-914.
32. Trach DD, Clemens JD, Ke NT, Thuy HT, Son ND, Canh DG, et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietman. Lancet 1997; 349: 231-235.
33. World Health Organization. Cholera 2004. WHO Wkly Epidemiol Rec 2005; 80: 261-268.
34. Briggs CL, Briggs CM. Stories in the time of cholera: Racial profiling during a medical nightmare. Berkeley, California: University of California Press; 2003.
35. Health system problems aggravate cholera outbreak in Zimbabwe. WHO News Releases 2008. December 10, 2008.